Pricing

Admanage.ai

Launch, manage, and learn from every ad in one workflow, across 15 ad channels.

15 ad channelsUnlimited launchesNo percentage of ad spend

Plans from

£199.99/mo

Flat monthly pricing

Product

Launch

Bulk Ad Launcher
Table launch
Sheets / CSV import
Post ID & Partnership Ads
Cloud creative imports
Frame.io import
Dropbox import

Automate

Automations
Rules
AI grouping
Naming templates

Analyze

Creative Reporting
Benchmarks
AppsFlyer
Triple Whale
Comments

Research & AI

AdScan / Brand Spy
Boards
Ask Ada
MCP / ChatGPT
Meta Ads MCP

Channel features & formats

Meta Ads
TikTok Ads
Google Ads
AppLovin
Snapchat Ads
Pinterest Ads
Reddit Ads
X Ads
LinkedIn Ads
Taboola Ads
Mintegral
Moloco Ads
Unity Ads
Apple Ads
ChatGPT Ads

Solutions

Agencies
Brands / In-house
Mobile apps
Customers & case studies

Resources

Blog
Facebook Ad Library
Free tools
Compare ad launchers
Docs & API
Changelog

Meta features

Bulk creative upload
Batch ad creation
Creative grouping
Individual ad editing
Multi-text variations
Creative enhancement control
Naming conventions
UTM parameters
Product extensions
Sitelinks
Multi-advertiser ads
Ad scheduling
Reuse existing ads
Video thumbnail selection
Client preview links
Google Drive upload
Ad set copy
Campaign copy
Multi-language Meta ads

Meta ad types

Image ads
Video ads
Carousel ads
Flexible ads
Post ID ads
Partnership post ads
Partnership sender ads
Lead form ads
Event response ads
App promotion ads

Integrations

Google Drive
Dropbox
YouTube
Timeliner
Frame.io
Box
Canva
SharePoint
Brandfolder
Bynder
AIR
Playbook
Shade
Iconik

Free tools

More resources

vs Meta Ads Manager
MCP Prompt Playbook
Brand Assets
AdManage Leaderboard
Support
Testimonials
Compare Platforms
AdManage vs Adtool

Company

Support
Affiliates
Perks
Careers
Terms of service
Privacy policy
Trust Center
Pricing
Pricing page
Real-Time Status
Check live status

Built by AdManage.ai. © 2026 All rights reserved.

Leave us a G2 review

Careers — we're hiring

Home
›
Dr. Michelle Sands ads
›
This ad

Dr. Michelle Sands video ad

See all Dr. Michelle Sands ads →

Aug 9, 2026

Strength isn’t just in the muscles we build, but in the peace we cultivate within. 🤍 Menopause, stress, hormonal changes — ...

instagram.com

Reach

315.2K

Est. spend

$4.7K

Ran for

137d

Format

video

Platforms

More from Dr. Michelle Sands

New Mayo Clinic data just revealed a massive gap in women’s healthcare. Despite overwhelming evidence that Menopausal Hormone Therapy (HRT) is safe and effective when started early in menopause, usage rates have actually DECLINED over the last 15 years. According to the study “United States Menopausal Hormone Therapy Usage Trends: An Observational Study” published in Mayo Clinic Proceedings, Volume 101, Issue 6, June 2026 (Faubion et al., N=13,372,648 women): 📉 Overall systemic HT use dropped from 4.4% in 2007 to just 1.7% in 2023 📉 Among women aged 50-54: only 3.4% using HT 📉 Among women aged 55-59: only 3.5% using HT 📉 Use was consistently highest among White women The authors concluded: “Despite substantial evidence and established guidelines supporting the efficacy and safety of menopausal HT, particularly when started early in menopause, usage rates have declined and remain low.” You don’t have to suffer. I’m here to help. My team and I love helping women look and feel like themselves again. . Source: Faubion SS, Safwan N, Saadedine M, et al. United States Menopausal Hormone Therapy Usage Trends: An Observational Study. Mayo Clin Proc. 2026;101(6):946-954. doi:10.1016/j.mayocp.2025.12.021194.7K reach

A new paper just exposed the truth: the studies that linked HRT to breast cancer were deeply flawed. We have been saying this for years but now we have all the data neatly bundled together. This week, The Scientist (Aug 5, 2026) published a piece by a University of Michigan gynecologist — backed by a new JAMA editorial — that finally broke down exactly how the research that scared an entire generation of women off hormones got it wrong. >THE WHI STUDY used women who were smokers, overweight, had preexisting health conditions, and were aged up to 79. This is NOT who starts HRT. >The culprit was MPA (medroxyprogesterone acetate) — a synthetic progestin we rarely prescribe today. Micronized progesterone is safer. >Women who took ESTROGEN ALONE showed ZERO increased breast cancer risk. >The FDA removed the black box warnings in 2025. Most doctors still haven’t caught up. >20+ studies show no increased risk for breast cancer survivors on HRT. And here’s what they’re NOT telling you: HRT has been shown across multiple studies to PROTECT women from heart disease, diabetes, dementia, osteoporosis, and many types of cancer — and reduce their risk of dying from any cause by up to 39%. This isn’t just about hot flashes. This is about longevity. Ready to get your hormones optimized safely? DM me the word “HORMONES” and I’ll send you the exact next steps.68.6K reach

GLP-1s like Tirzepatide aren’t just “weight loss drugs.” They protect your heart, reduce inflammation, reverse fatty liver, rewire your brain’s cravings, and even got FDA-approved for sleep apnea. The science is wild. But let’s talk about the elephant in the room. The downsides? Muscle loss and a slower metabolism. And yeah — if you’re just injecting and sitting on the couch eating 1,200 calories a day, that WILL happen. Here’s how we combat that with our patients: ✅ Microdosing — You don’t always need the max dose. A lower, strategic dose gives you the metabolic benefits without torching your lean mass. ✅ 1 gram of protein per pound of lean bodyweight — This is non-negotiable. Protein is the building block that preserves (and builds) muscle while you’re losing fat. ✅ Weight training — The single best signal you can send your body to KEEP your muscle. Lift heavy. Train hard. Your body will prioritize holding onto that tissue. Do all three, and you’re not just losing weight — you’re recomposing your entire body while getting the anti-aging, anti-inflammatory, cardioprotective benefits of GLP-1s. Want access to GLP-1s like Tirzepatide, testosterone, sexual enhancement meds, or longevity peptides? Our brand new telemedicine platform makes it hassle-free — prescribed by a licensed physician and shipped discreetly to your door. Head to glownaturalwellness.com to learn more38.6K reach

“It’s just a UTI.” Until it isn’t. After menopause, declining estrogen doesn’t just cause vaginal dryness. It changes the vaginal environment itself. Less estrogen → fewer protective lactobacilli → higher vaginal pH → an environment that can make recurrent urinary tract infections more likely. And vaginal estrogen may dramatically change that equation. One randomized controlled trial published in The New England Journal of Medicine found that women using vaginal estriol went from an average of: 5.9 UTIs per year → just 0.5 That’s approximately a 92% reduction in the annual UTI rate. And it wasn’t just one study. A meta-analysis of 5 randomized controlled trials involving 1,936 women found vaginal estrogen reduced the risk of recurrent UTIs by approximately 58% compared with placebo But here’s where this becomes about much more than an uncomfortable infection. A UTI can ascend to the kidneys, enter the bloodstream and contribute to urosepsis—a potentially life-threatening medical emergency. And now we have some fascinating new data. A 2026 study of 1,891,956 women with recurrent UTIs found that women prescribed vaginal estrogen had significantly lower odds of: Sepsis. Hospitalization. And death. Depending on age, sepsis occurred in 4.2–10.4% of women prescribed vaginal estrogen compared with 8.5–24.1% of women who weren’t. This was an observational study, so it shows an association rather than proving vaginal estrogen directly prevented those outcomes. But combine that with randomized trials showing vaginal estrogen reduces recurrent UTIs—and suddenly this conversation looks very different. Maybe we should stop treating vaginal estrogen like it’s “just” about dryness. For some women, restoring estrogen locally may be about vaginal health, urinary health, sexual health—and potentially preventing complications that can become very serious. And there’s a reason the American Urological Association recommends vaginal estrogen for peri- and postmenopausal women with recurrent UTIs to reduce their risk of future infections. Research in first comment28.8K reach

“I was offered antidepressants by 3 different doctors between the ages of 41 and 45. Not one of them even mentioned perimenopause.” — Candance That’s a real quote from one of my patients. And it’s not rare — it’s the norm. The symptoms of perimenopause — anxiety, depression, insomnia, brain fog, rage — look identical to a psychiatric disorder on a checklist. So doctors reach for SSRIs. But SSRIs don’t fix a hormone deficiency. They can’t replace estrogen’s role in serotonin production. They can’t restore progesterone’s calming effect on the nervous system. Instead they create a bigger health gap and contribute to sexual dysfunction and relationship issues, while the body and brain continues to struggle in a hormone deficient state.. The standard of care is failing women in midlife. And most of them don’t even know it. If you were prescribed antidepressants without anyone checking your hormones first, you were failed by the system. Not by your body. I’m curious, Were you ever given antidepressants before anyone mentioned perimenopause? I was, and I am wondering how many others reading this post experienced the same.20.1K reach

New Mayo Clinic data just revealed a massive gap in women’s healthcare. Despite overwhelming evidence that Menopausal Hormone Therapy (HRT) is safe and effective when started early in menopause, usage rates have actually DECLINED over the last 15 years. According to the study “United States Menopausal Hormone Therapy Usage Trends: An Observational Study” published in Mayo Clinic Proceedings, Volume 101, Issue 6, June 2026 (Faubion et al., N=13,372,648 women): 📉 Overall systemic HT use dropped from 4.4% in 2007 to just 1.7% in 2023 📉 Among women aged 50-54: only 3.4% using HT 📉 Among women aged 55-59: only 3.5% using HT 📉 Use was consistently highest among White women The authors concluded: “Despite substantial evidence and established guidelines supporting the efficacy and safety of menopausal HT, particularly when started early in menopause, usage rates have declined and remain low.” You don’t have to suffer. I’m here to help. My team and I love helping women look and feel like themselves again. . Source: Faubion SS, Safwan N, Saadedine M, et al. United States Menopausal Hormone Therapy Usage Trends: An Observational Study. Mayo Clin Proc. 2026;101(6):946-954. doi:10.1016/j.mayocp.2025.12.0212.2K reach

“It’s just a UTI.” Until it isn’t. After menopause, declining estrogen doesn’t just cause vaginal dryness. It changes the vaginal environment itself. Less estrogen → fewer protective lactobacilli → higher vaginal pH → an environment that can make recurrent urinary tract infections more likely. And vaginal estrogen may dramatically change that equation. One randomized controlled trial published in The New England Journal of Medicine found that women using vaginal estriol went from an average of: 5.9 UTIs per year → just 0.5 That’s approximately a 92% reduction in the annual UTI rate. And it wasn’t just one study. A meta-analysis of 5 randomized controlled trials involving 1,936 women found vaginal estrogen reduced the risk of recurrent UTIs by approximately 58% compared with placebo But here’s where this becomes about much more than an uncomfortable infection. A UTI can ascend to the kidneys, enter the bloodstream and contribute to urosepsis—a potentially life-threatening medical emergency. And now we have some fascinating new data. A 2026 study of 1,891,956 women with recurrent UTIs found that women prescribed vaginal estrogen had significantly lower odds of: Sepsis. Hospitalization. And death. Depending on age, sepsis occurred in 4.2–10.4% of women prescribed vaginal estrogen compared with 8.5–24.1% of women who weren’t. This was an observational study, so it shows an association rather than proving vaginal estrogen directly prevented those outcomes. But combine that with randomized trials showing vaginal estrogen reduces recurrent UTIs—and suddenly this conversation looks very different. Maybe we should stop treating vaginal estrogen like it’s “just” about dryness. For some women, restoring estrogen locally may be about vaginal health, urinary health, sexual health—and potentially preventing complications that can become very serious. And there’s a reason the American Urological Association recommends vaginal estrogen for peri- and postmenopausal women with recurrent UTIs to reduce their risk of future infections. Research in first comment1.5K reach

Strength isn’t just in the muscles we build, but in the peace we cultivate within. 🤍 Menopause, stress, hormonal changes — they don’t just affect the body. They affect how we feel about ourselves, how we connect with others, and how we show up in the world. But here’s what I know to be true: when we stop fighting our bodies and start working with them, everything shifts. True wellness is biohacking your mind just as much as your body. It’s natural medicine, intentional movement, deep rest, honest relationships, and the courage to put yourself first. The foundation of all of it? The relationship you have with yourself. Find your center. Everything else follows. Save this if it resonates, and share it with a woman who needs to hear it today.296 reach

It’s finally here!! In addition to our innovative CLEAN HORMONES line of toxin-free Bioidentical hormones, GNW now offers EASY access to Testosterone, GLP-1’s, sexual performance aids, and peptides for women and men. All without gaslighting or hassle! Convenient, affordable, complete care. Medical oversight included with the price of your medication. To celebrate the launch, your first prescription is 15% off. Head over to Glownaturalwellness.com and click on telemedicine to learn more. Because I witnessed firsthand what a nightmare it is to get proper hormone and longevity care, I decided to remove all the red tape and make things super simple.47 reach

“I was offered antidepressants by 3 different doctors between the ages of 41 and 45. Not one of them even mentioned perimenopause.” — Candance That’s a real quote from one of my patients. And it’s not rare — it’s the norm. The symptoms of perimenopause — anxiety, depression, insomnia, brain fog, rage — look identical to a psychiatric disorder on a checklist. So doctors reach for SSRIs. But SSRIs don’t fix a hormone deficiency. They can’t replace estrogen’s role in serotonin production. They can’t restore progesterone’s calming effect on the nervous system. Instead they create a bigger health gap and contribute to sexual dysfunction and relationship issues, while the body and brain continues to struggle in a hormone deficient state.. The standard of care is failing women in midlife. And most of them don’t even know it. If you were prescribed antidepressants without anyone checking your hormones first, you were failed by the system. Not by your body. I’m curious, Were you ever given antidepressants before anyone mentioned perimenopause? I was, and I am wondering how many others reading this post experienced the same.13 reach

All Dr. Michelle Sands ads ↗

A world of creative inspiration

Your next great ad
starts with an idea.

Explore 13.5M+ ads in Admanage. Find fresh angles, follow the brands that inspire you, and save your next campaign’s starting point.

13.5M+

Headway

Coin Master

Motion

An entire library. Endless possibilities.

Discover new ideasBuild your swipe fileExplore brands you love